Grifols invests in Biotest to increase patient access to plasma therapies

Our mission is to improve the health and well-being of patients around the world. Since 1909, we have advanced science, inspired innovation, and supported the scientific community and its research efforts worldwide.

Thanks to our donors' generosity we develop essential plasma medicines to treat chronic, rare and, at times, life-threatening conditions. We also provide diagnostic solutions, instruments, and services for blood banks, donation centers, hospitals, and pharmacies.

We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the laboratory Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos in Barcelona.

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies.

We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.

Since Grifols was founded, our ongoing innovation has helped shape industry standards in the plasma industry.